May 12, 2020

May 19, 2020

The University of Cincinnati College of Medicine is awarding 51 master’s and 14 doctoral degrees during a virtual graduation ceremony set for Friday, May 22, from 2-3 p.m. A link for this virtual ceremony is being sent to graduating students to share with their networks.

May 18, 2020

The Center for Clinical and Translational Science and Training (CCTST) has received its third round of funding through the National Institute of Health (NIH) National Center for Advancing Translational Sciences’ Clinical and Translational Award (CTSA) program. This $22.1 million award will enable the CCTST to continue supporting investigators in maximizing the impact of clinical and translational research to improve individual and population health in Greater Cincinnati and beyond.

July 15, 2020

Researchers at UC are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial. The research trial, called Sirolimus Treatment in Hospitalized Patients with COVID-19 Pneumonia (SCOPE), will examine the Food and Drug Administration-approved medication that is most commonly used to prevent organ rejection in patients with kidney transplants. It is also FDA-approved for the treatment of a rare lung disease, LAM.

April 28, 2020

The University of Cincinnati College of Medicine is collecting specimens from COVID-19 patients to be stored in a biorepository as part of the Cincinnati COVID-19 Repository (CCR) effort. The specimens will be used by researchers to learn more about the COVID-19 infection and possible treatments and preventions for not only this disease but possibly diseases of the future.

June 17, 2020

Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2. UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19.

August 25, 2020

Researcher clinicians at the University of Cincinnati College of Medicine have administered the first doses in a groundbreaking clinical trial that will evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.

October 12, 2020

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits.

June 30, 2021

Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18. The study was published in PLOS One in May 2021. The researchers would like to see this study have an impact on public health policy as well as the frequency of HIV screening in emergency departments across the country.

April 27, 2023

This year, the university is celebrating the return of UC Serves – a day for staff and faculty to share the experience of intentional, focused service to the communities surrounding the University of Cincinnati campuses and beyond. The day of service helps connect UC with community neighbors and build stronger connections among university employees. UC Serves brings staff and faculty to the front lines in supporting UC’s institutional commitment to service and community impact in support of our local non-profit partners.